Start Date
March 7, 2018
Primary Completion Date
May 29, 2019
Study Completion Date
May 29, 2019
Fluticasone Furoate/Vilanterol
Fluticasone furoate/vilanterol will be supplied as inhalation powder in ELLIPTA DPI. It will contain 2 strips with 30 blisters per strip. First strip will contain fluticasone furoate 100 mcg dry white powder blended with lactose. Second strip will contain vilanterol 25 mcg dry white powder blended with lactose and magnesium stearate.
Fluticasone Furoate
Fluticasone furoate will be supplied as inhalation powder in ELLIPTA DPI. It will contain a single strip with 30 blisters, containing fluticasone furoate 100 mcg dry white powder blended with lactose.
Salbutamol/Albuterol
Salbutamol/albuterol will be provided to subjects to use as rescue medication on an as-needed basis.
Lead Sponsor
Collaborators (1)
Parexel
INDUSTRY
GlaxoSmithKline
INDUSTRY